It was noted that in pathologies such as lupus [100] or rheumatoid arthritis [101], the number of CD4+ T lymphocytes producing IL-21 increased, suggesting that blocking this IL could improve the conditions of these pathologies. This evidence concerns the gene IL21 and systemic lupus erythematosus.